Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology

被引:250
|
作者
Tsao, Connie W. [1 ,2 ,3 ]
Vasan, Ramachandran S. [1 ,4 ,5 ]
机构
[1] Framingham Heart Dis Epidemiol Study, Framingham, MA USA
[2] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiovasc, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Boston Univ, Sch Med, Sect Cardiol & Preventat Med, Boston, MA 02118 USA
[5] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
基金
美国国家卫生研究院;
关键词
GENOME-WIDE ASSOCIATION; INDEPENDENT RISK-FACTOR; LEFT-VENTRICULAR MASS; CHRONIC ATRIAL-FIBRILLATION; SEQUENCING IDENTIFIES RARE; HIGH-DENSITY-LIPOPROTEIN; FLOW-MEDIATED DILATION; ANKLE-BRACHIAL INDEX; BLOOD-PRESSURE; LONG-TERM;
D O I
10.1093/ije/dyv337
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The Framingham Heart Study (FHS) has conducted seminal research defining cardiovascular disease (CVD) risk factors and fundamentally shaping public health guidelines for CVD prevention over the past five decades. The success of the Original Cohort, initiated in 1948, paved the way for further epidemiological research in preventive cardiology. Due to the keen observations suggesting the role of shared familial factors in the development of CVD, in 1971 the FHS began enroling the second generation cohort, comprising the children of the Original Cohort and the spouses of the children. In 2002, the third generation cohort, comprising the grandchildren of the Original Cohort, was initiated to additionally explore genetic contributions to CVD in greater depth. Additionally, because of the predominance of White individuals of European descent in the three generations of FHS participants noted above, the Heart Study enrolled the OMNI1 and OMNI2 cohorts in 1994 and 2003, respectively, aimed to reflect the current greater racial and ethnic diversity of the town of Framingham. All FHS cohorts have been examined approximately every 2-4 years since the initiation of the study. At these periodic Heart Study examinations, we obtain a medical history and perform a cardiovascular-focused physical examination, 12-lead electrocardiography, blood and urine samples testing and other cardiovascular imaging studies reflecting subclinical disease burden. The FHS has continually evolved along the cutting edge of cardiovascular science and epidemiological research since its inception. Participant studies now additionally include study of cardiovascular imaging, serum and urine biomarkers, genetics/genomics, proteomics, metabolomics and social networks. Numerous ancillary studies have been established, expanding the phenotypes to encompass multiple organ systems including the lungs, brain, bone and fat depots, among others. Whereas the FHS was originally conceived and designed to study the epidemiology of cardiovascular disease, it has evolved over the years with staggering expanded breadth and depth that have far greater implications in the study of the epidemiology of a wide spectrum of human diseases. The FHS welcomes research collaborations using existing or new collection of data. Detailed information regarding the procedures for research application submission and review are available at [http://www.framinghamheartstudy.org/researchers/index.php].
引用
收藏
页码:1800 / 1813
页数:14
相关论文
共 50 条
  • [41] The Association between the Gut Microbiota and Bone Density and Microarchitecture: the Framingham Heart Study (FHS) and the Osteoporotic Fractures in Men Study (MrOS)
    Langsetmo, Lisa
    Kuntz, Thomas
    Morgan, Xochitl
    Okoro, Paul
    Farsijani, Sameneh
    Bouxsein, Mary L.
    Burghardt, Andrew J.
    Kado, Deborah M.
    Pacifici, Roberto
    Lane, Nancy E.
    Sahni, Shivani
    Dufour, Alyssa B.
    Hsu, Yi-Hsiang
    Orwoll, Eric S.
    Kiel, Douglas P.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 278 - 278
  • [42] Cardiovascular risk factor mediation of the effects of education and Genetic Risk Score on cardiovascular disease: a prospective observational cohort study of the Framingham Heart Study
    Powell, Katie L.
    Stephens, Sebastien R.
    Stephens, Alexandre S.
    BMJ OPEN, 2021, 11 (01):
  • [43] Components of Hemodynamic Load and Cardiovascular Events The Framingham Heart Study
    Cooper, Leroy L.
    Rong, Jian
    Benjamin, Emelia J.
    Larson, Martin G.
    Levy, Daniel
    Vita, Joseph A.
    Hamburg, Naomi M.
    Vasan, Ramachandran S.
    Mitchell, Gary F.
    CIRCULATION, 2015, 131 (04) : 354 - U1157
  • [44] Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study
    Lahoz, C
    Schaefer, EJ
    Cupples, LA
    Wilson, PWF
    Levy, D
    Osgood, D
    Parpos, S
    Pedro-Botet, J
    Daly, JA
    Ordovas, JM
    ATHEROSCLEROSIS, 2001, 154 (03) : 529 - 537
  • [45] HEART-RATE AND CARDIOVASCULAR MORTALITY - THE FRAMINGHAM-STUDY
    KANNEL, WB
    KANNEL, C
    PAFFENBARGER, RS
    CUPPLES, LA
    AMERICAN HEART JOURNAL, 1987, 113 (06) : 1489 - 1494
  • [46] Diabetes and Cardiovascular Disease: Insights from the Framingham Heart Study
    Qazi, Mohammad U.
    Malik, Shaista
    GLOBAL HEART, 2013, 8 (01) : 43 - 48
  • [47] Mitral valve prolapse reconsidered: Prevalence and epidemiology in the framingham heart study
    Freed, LA
    Levy, D
    Levine, RA
    Larson, MG
    Evans, JC
    Fuller, DL
    Lehman, B
    Benjamin, AJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 303A - 303A
  • [48] Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study
    Meigs, JB
    Nathan, DM
    Cupples, LA
    Wilson, PWF
    Singer, DE
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (04) : 411 - 417
  • [49] Relation of MRI visible perivascular spaces with global and regional brain structural connectivity measures: The Framingham Heart Study (FHS)
    Ekenze, Oluchi
    Seiler, Stephan
    Pinheiro, Adlin
    Decarli, Charles
    Parva, Pedram
    Habes, Mohamad
    Charidimou, Andreas
    Maillard, Pauline
    Beiser, Alexa
    Seshadri, Sudha
    Demissie, Serkalem
    Romero, Jose Rafael
    NEUROBIOLOGY OF AGING, 2025, 150 : 1 - 8
  • [50] Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study
    Mellinger, Jessica L.
    Pencina, Karol M.
    Massaro, Joseph M.
    Hoffmann, Udo
    Seshadri, Sudha
    Fox, Caroline S.
    O'Donnell, Christopher J.
    Speliotes, Elizabeth K.
    JOURNAL OF HEPATOLOGY, 2015, 63 (02) : 470 - 476